Literature DB >> 2772184

Graves ophthalmopathy: MR imaging of the orbits.

N Hosten1, B Sander, M Cordes, C J Schubert, W Schörner, R Felix.   

Abstract

Thirty-nine patients with Graves ophthalmopathy were examined with magnetic resonance (MR) imaging at 0.5 T with use of a surface coil. T1- and T2-weighted spin-echo images were obtained, and T2 relaxation times of eye muscles and retrobulbar fat were calculated from a multiecho sequence. Normal values for T2 relaxation times of eye muscle were obtained by examining nine control subjects. MR imaging demonstrated eye muscle enlargement in 23 patients. Visual examination of T2-weighted and calculated T2 images showed areas of high signal intensity in enlarged eye muscles of 12 of 23 patients. Calculated T2 relaxation times of eye muscles differed significantly between control subjects and patients with stage III and IV disease. Signal intensity characteristics of these changes, as well as their correlation with well-known histologic findings, suggested their interpretation as edema caused by acute inflammation. Since computed tomography is not able to depict eye muscle edema, the MR findings of structural changes within enlarged eye muscles might have an impact on therapeutic decisions concerning the application of anti-inflammatory drugs.

Entities:  

Mesh:

Year:  1989        PMID: 2772184     DOI: 10.1148/radiology.172.3.2772184

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

Review 1.  Magnetic resonance imaging of orbital tumors.

Authors:  A J Lemke; I Kazi; R Felix
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

Review 2.  [Inflammatory diseases of the orbit].

Authors:  A Zimmer; W Reith
Journal:  Radiologe       Date:  2008-12       Impact factor: 0.635

3.  Update on advanced imaging options for thyroid-associated orbitopathy.

Authors:  Michael P Rabinowitz; Jacqueline R Carrasco
Journal:  Saudi J Ophthalmol       Date:  2012-10

4.  Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy.

Authors:  Ji Sung Han; Hyung Suk Seo; Young Hen Lee; Hwa Lee; Sang-Il Suh; Eun-Kee Jeong; Nabraj Sapkota; Ki Joon Kim
Journal:  Neuroradiology       Date:  2016-11-14       Impact factor: 2.804

5.  [Calculation of orbital fat volumes for determining treatment timing for thyroid- associated ophthalmopathy].

Authors:  Wei Jiang; Qiu-Yue Cai; Zhang-Fang Li; Zhi-Yi Chen; Yao-Sheng Luo; Shi-di Hu; Jie Shen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

6.  Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg.

Authors:  Letterio Salvatore Politi; Claudia Godi; Gabriella Cammarata; Alessandro Ambrosi; Antonella Iadanza; Roberto Lanzi; Andrea Falini; Stefania Bianchi Marzoli
Journal:  Eur Radiol       Date:  2014-02-12       Impact factor: 5.315

Review 7.  [Appearance of orbital diseases on MRI].

Authors:  I Kazi; R Felix; A-J Lemke
Journal:  Radiologe       Date:  2005-09       Impact factor: 0.635

8.  Non-surgical orbital decompression using diuresis in dysthyroid optic neuropathy: a case report.

Authors:  Annamaria Erdei; Annamaria Gazdag; Bernadett Ujhelyi; Edit B Nagy; Ervin Berenyi; Eszter Berta; Zita Steiber; Sandor Barna; Emese Mezosi; Miklos Bodor; Endre V Nagy
Journal:  Eur Thyroid J       Date:  2022-08-11

Review 9.  Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy.

Authors:  Allan C Pieroni Gonçalves; Eloísa M M S Gebrim; Mário L R Monteiro
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.